SGLT-2 Inhibitors Versus GLP-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus: A Propensity Score-Matched Cohort Study Comparing Adherence and Persistence with Specific Reference to Cardiovascular Disease
Pharmaceuticals (Basel, Switzerland) · 2026 Oct 10 · González-González MA, Pedrosa-Naudín MA, Fernández-Lázaro D et
MH
By Maren Holt · Senior Reporter, GLP-1
Oct 9 20:00 ETSource: Pharmaceuticals (Basel, Switzerland)
From the source
Read at pubmed.ncbi.nlm.nih.govSGLT-2 Inhibitors Versus GLP-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus: A Propensity Score-Matched Cohort Study Comparing Adherence and Persistence with Specific Reference to Cardiovascular Disease
Pharmaceuticals (Basel, Switzerland) · 2026 Oct 10 · González-González MA, Pedrosa-Naudín MA, Fernández-Lázaro D et al.
Source URL https://pubmed.ncbi.nlm.nih.gov/42943304/
